zum Inhalt
Header Image

Wie verlässlich ist Evidenz in der Medizin?

-
Erwin-Schrödinger-Saal
Plenary / Debate
in englischer Sprache

Ist die evidenzbasierte Medizin (EBM) verlässlicher als die klinische Erfahrung? Welche Grenzen hat die wissenschaftliche Evidenz? Wie kann die Kluft zwischen klinischer Forschung und der Praxis überbrückt werden?

Vortragende

C.F. Rehnborg Professor in Disease Prevention and Director, Prevention Research Center, Stanford University School of Medicine, Stanford
Professor, Institute of Pharmacology, Medical University of Vienna; Scientific Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna Chair

Prof. John IOANNIDIS

C.F. Rehnborg Professor in Disease Prevention and Director, Prevention Research Center, Stanford University School of Medicine, Stanford

 C.F. Rehnborg Chair in Disease Prevention at Stanford University, Stanford
 Professor of Medicine and Director of the Stanford Prevention Research Center, Stanford University School of Medicine, Stanford
1999-2003 Chair, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina
  Doctorate in Biopathology
  Specialisation in Internal Medicine and Infectious Diseases, Harvard University and Tufts University, NIH - National Institutes of Health, Johns Hopkins University School of Medicine and Tufts University School of Medicine, Boston
1990 Study of Medicine, University of Athens
since 1996 Adjunct Faculty, Tufts University School of Medicine, Boston
since 2002 Professor, Tufts University School of Medicine, Boston
  Adjunct Professor of Epidemiology, Harvard School of Public Health, Boston
  Visiting Professor of Epidemiology and Bio Statistics, Imperial College, London
since 2008 Leader, Genetics/Genomics Component of CTSI - Tufts Clinical and Translational Science Institute and CGEM - Center for Genetic Epidemiology and Modeling, Tufts Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston

Dr. Giulio SUPERTI-FURGA

Professor, Institute of Pharmacology, Medical University of Vienna; Scientific Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna

1987-1991 Ph.D., Molecular Biology, University of Zurich
1991-1993 Postdoctoral fellow, EMBO and EU Postdoc EMBL - European Molecular Biology Laboratory, Heidelberg
1993-2004 Staff Scientist, Team Leader; EMBL - European Molecular Biology Laboratory, Heidelberg
1997-2000 Guest Professor, Molecular Biology, University of Bologna
2000-2005 Founder and Scientific Director, Cellzome AG and Inc., Heidelberg and Cambridge
2005-2014 Guest Professor, Molecular Pharmacology, Medical University of Vienna
since 2005 Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna
since 2015 Professor, Medical Systems Biology, Center for Physiology and Pharmacology, Medical University of Vienna
since 2017 Member, Scientific Council of the European Research Council, Brussels

Gesundheitsgespräche

Timetable einblenden